Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

January 16, 2026

Study Completion Date

July 30, 2026

Conditions
Opioid AbusePrescription Opioid Abuse
Interventions
BEHAVIORAL

Clinical Decision Support Tool (Moderate Risk)

Moderate risk patients will get brief motivational intervention for medication misuse and an offer of naloxone dispensation.

BEHAVIORAL

Clinical Decision Support Tool (High Risk)

Those with high risk will receive a brief motivational intervention leading to warm handoff treatment linkage intervention to primary or specialty substance use care with an offer for naloxone dispensation.

OTHER

Standard of Care

Ohio State law requires pharmacist to not dispense an opioid supply \>90 days, with a specific prohibition on dispensations ≥14 days after prescriptions are issued. Pharmacists are also required to perform a universal prescription drug medication review before initial dispensation and offer brief counseling (e.g., unstandardized information about medication safety) for new/modified prescription therapies.

Trial Locations (2)

45267

RECRUITING

University of Cincinnati, Cincinnati

84108

RECRUITING

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

University of Cincinnati

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Utah

OTHER